Omnia Biologics Inc is categorized under Scientific Consultants in Rockville, MD and active since 2002.
Omnia Biologics Inc was established in 2002, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Scientific Consultants business, which does work in the B2B market, and is classified as a Scientific Consultants, under code number 541690 by the NAICS.
If you are seeking more information, feel free to contact Dale Vanderputten at the company’s single location by writing to 12115 Parklawn Drive # D, Rockville, Maryland MD 20852 or by phoning (301) 984-5928. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Omnia Biologics Inc |
| Contact Person: | Dale Vanderputten |
| Address: | 12115 Parklawn Drive # D, Rockville, Maryland 20852 |
| Phone Number: | (301) 984-5928 |
| Website Address: | omniabiologics.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Scientific Consultants |
| SIC Code: | 8999 |
| NAICS Code: | 541690 |
| Share This Business: |
Omnia Biologics Inc was started in 2002 to provide professional Scientific Consultants under the SIC code 8999 and NAICS code 541690. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dale Vanderputten for inquiries that concern Omnia Biologics Inc by calling the company number (301) 984-5928, as your correspondence is most welcome. Additionally, the physical location of the single location of Omnia Biologics Inc can be found at the coordinates 39.056745,-77.108766 as well as the street address 12115 Parklawn Drive # D in Rockville, Maryland 20852.
For its online presence, you may visit Omnia Biologics Inc’s website at omniabiologics.com and engage with its social media outlets through on Twitter and on Facebook.